AASM (2001) The international classification of sleep disorders, revised: diagnosis and coding manual. Westchester, IL: American Academy of Sleep Medicine.
Absi EG, Addy M, Adams D Dentine hypersensitivity. The development and evaluation of a replica technique to study sensitive and non-sensitive cervical dentine. J Clin Periodontol. 1989 Mar;16(3):190-5.
Bartlett DW, Shah P A critical review of non-carious cervical (wear) lesions and the role of abfraction, erosion, and abrasion. J Dent Res. 2006 Apr;85(4):306-12. Review.
Burke FJ, Whitehead SA, McCaughey AD Contemporary concepts in the pathogenesis of the Class V non-carious lesion. Dent Update. 1995 Jan-Feb;22(1):28-32. Review.
Duran I, Sengun A The long-term effectiveness of five current desensitizing products on cervical dentine sensitivity. J Oral Rehabil. 2004 Apr;31(4):351-6.
Ide M, Morel AD, Wilson RF, Ashley FP The rĂ´le of a dentine-bonding agent in reducing cervical dentine sensitivity. J Clin Periodontol. 1998 Apr;25(4):286-90.
Lavigne GJ, Manzini C, Kato T (2005) Sleep Bruxism. In: Principles and practice of sleep medicine. MH Kryger, T Roth and WC Dement editors. Philadelphia: Elsevier, pp. 946-59
LittleStar ML, Summitt JB Non-carious cervical lesions: an evidenced-based approach to their diagnosis. Tex Dent J. 2003 Oct;120(10):972-80. Review.
Lussi A, Schaffner M Progression of and risk factors for dental erosion and wedge-shaped defects over a 6-year period. Caries Res. 2000 Mar-Apr;34(2):182-7.
Lyttle HA, Sidhu N, Smyth B A study of the classification and treatment of noncarious cervical lesions by general practitioners. J Prosthet Dent. 1998 Mar;79(3):342-6.
Miller E, Deleger S, Murphy J (2002) Implementing and managing adaptive designs for clinical trials. http://www.pharmaceutical-int.com/categories/interactive-clinical-technologies-inc/implementing-and-managing-adaptive-designs-for-clinical-trials.asp.
Rees JS The biomechanics of abfraction. Proc Inst Mech Eng H. 2006 Jan;220(1):69-80. Review.
Rimondini L, Baroni C, Carrassi A Ultrastructure of hypersensitive and non-sensitive dentine. A study on replica models. J Clin Periodontol. 1995 Dec;22(12):899-902.
Telles D, Pegoraro LF, Pereira JC Prevalence of noncarious cervical lesions and their relation to occlusal aspects: a clinical study. J Esthet Dent. 2000;12(1):10-5.
Trowbridge HO, Silver DR A review of current approaches to in-office management of tooth hypersensitivity. Dent Clin North Am. 1990 Jul;34(3):561-81. Review.
Tyas MJ The Class V lesion--aetiology and restoration. Aust Dent J. 1995 Jun;40(3):167-70. Review.
Yates RJ, Newcombe RG, Addy M Dentine hypersensitivity: a randomised, double-blind placebo-controlled study of the efficacy of a fluoride-sensitive teeth mouthrinse. J Clin Periodontol. 2004 Oct;31(10):885-9.
Zantner C, Popescu O, Martus P, Kielbassa AM Randomized clinical study on the efficacy of a new lacquer for dentine hypersensitivity. Schweiz Monatsschr Zahnmed. 2006;116(12):1232-7.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.